Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature (3)
Cell Research (1)
Nature Communications (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (5)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Cancer
Cell biology
Chemical biology
Drug discovery
Genetics
Molecular biology
Oncology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–5 of 5 results

Advanced filters: Author: Alexander Spektor Clear advanced filters

Targeting G1–S-checkpoint-compromised cancers with cyclin A/B RxL inhibitors

Dual cyclin A/B RxL inhibitors selectively kill small cell lung cancer cells and other cancer cells with high E2F activity.

Shilpa Singh
Catherine E. Gleason
Matthew G. Oser
ResearchOpen Access20 Aug 2025
Nature

P: 1-12
CDK5–cyclin B1 regulates mitotic fidelity

Cyclin B1 is a mitotic co-factor of CDK5.

Xiao-Feng Zheng
Aniruddha Sarkar
Dipanjan Chowdhury
Research04 Sept 2024
Nature

Volume: 633, P: 932-940
Chromothripsis from DNA damage in micronuclei

The mechanism for chromothripsis, “shattered” chromosomes that can be observed in cancer cells, is unknown; here, using live-cell imaging and single-cell sequencing, chromothripsis is shown to occur after a chromosome is isolated into a micronucleus, an abnormal nuclear structure.

Cheng-Zhong Zhang
Alexander Spektor
David Pellman
Research27 May 2015
Nature

Volume: 522, P: 179-184
53BP1 loss elicits cGAS-STING-dependent antitumor immunity in ovarian and pancreatic cancer

p53-binding protein 1 (53BP1) is a component of the DNA double-strand break signaling and repair. Here the authors show that that loss of 53BP1 in cancer cells leads to cGAS/STING pathway activation and anti-tumor immune responses in ovarian and pancreatic cancer models.

Yajie Sun
Jeffrey Patterson-Fortin
Dipanjan Chowdhury
ResearchOpen Access06 Aug 2024
Nature Communications

Volume: 15, P: 1-16
Regulators of tubulin polyglutamylation control nuclear shape and cilium disassembly by balancing microtubule and actin assembly

Lei Wang
Sharad C. Paudyal
Brian D. Dynlacht
Research15 Nov 2021
Cell Research

Volume: 32, P: 190-209